Journal of Inborn Errors of Metabolism and Screening

Aims & Scope

The Journal of Inborn Errors of Metabolism and Screening (JIEMS) is an online peer-reviewed open access journal devoted to publishing clinical and experimental research in inherited metabolic disorders and screening, for health professionals and scientists.

Original research articles published in JIEMS range from basic findings that have implications for disease pathogenesis and therapy, passing through diagnosis and screening of metabolic diseases and genetic conditions, and therapy development and outcomes as well.

Original articles, reviews on specific topics, brief communications and case reports are welcome.

JIEMS aims to become a key resource for geneticists, genetic counselors, biochemists, molecular biologists, reproductive medicine researchers, obstetricians/gynecologists, neonatologists, pediatricians, pathologists and other health professionals interested in inborn errors of metabolism and screening.

View Aims & Scope

---

Metrics & Ranking

Journal Rank

Year	Value
2024	20981

Journal Citation Indicator

Year	Value
2024	31

SJR (SCImago Journal Rank)

Year	Value
2024	0.203

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	15

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Link Between Hyperhomocysteinemia and Hypomethylation

  Citation: 44

  Authors: Madalena, Diane E., Rita

• Arginine and Citrulline for the Treatment of MELAS Syndrome

  Citation: 42

  Authors: Ayman W., Mohammed, Fernando

• Lysosomes, Lysosomal Storage Diseases, and Inflammation

  Citation: 37

  Authors: Calogera M.

• An Adapted Clinical Measurement Tool for the Key Symptoms of CLN2 Disease

  Citation: 29

  Authors: Kathleen W., Angela, Miriam, Peter, Temitayo, David R., Alfried

• Coenzyme Q₁₀ in the Treatment of Mitochondrial Disease

  Citation: 28

  Authors: Viruna, Annapurna, Luke, Delia, Raquel, Rafael, Iain

• Mitochondrial Disease and Anesthesia

  Citation: 24

  Authors: Vincent C., Elliot J., Philip G.

• Lysosomal Storage Diseases

  Citation: 22

  Authors: Joseph, Jeremiah A.

• The Challenge of Diagnosis and Indication for Treatment in Fabry Disease

  Citation: 21

  Authors: Marco A., Carolina S., Sandra O., Patricia, Vanessa G., Vania, João B., Ana M.

• A New Phe-Free Protein Substitute Engineered to Allow a Physiological Absorption of Free Amino Acids for Phenylketonuria

  Citation: 20

  Authors: Nadia, Guglielmo, Valentina, Alessandra, Andrea, Giorgio

• Clinical Trials in Mitochondrial Disease

  Citation: 19

  Authors: Gregory M., Bruce H.

---